drugset / Trial / NCT02100748

A Study of TRV130 for the Treatment of Pain After Bunionectomy

NCT02100748

Phase 2 Completed 333 enrolled Trevena Inc.
RandomizedParallel-groupTriple-blindTreatment

Summary

The primary objective is to evaluate the analgesic efficacy of IV TRV130 compared with placebo in patients with acute postoperative pain after bunionectomy.

Timeline

Start
2014-04
Primary completion
2014-10
Completion
2014-10

Drugs

EvaluationDrugModalityDoseRoute
Comparator Morphine Other / unclassified 4 mg Intravenous
Subject Oliceridine Other / unclassified 1 mg Intravenous
Subject Oliceridine Other / unclassified 2 mg Intravenous
Subject Oliceridine Other / unclassified 3 mg Intravenous
Subject Oliceridine Other / unclassified 4 mg Intravenous

Indications

No indication recorded.